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Introduction
Primary care informatics is the scientiﬁc discipline
which seeks to improve health andmedical care through
the better use of data, information and knowledge.1
However, for use to be made of data they need to be
provided in a form whereby they can readily be
processed into information. In a previous editorial
we attacked the use of codes which did not say whether
a plasma (blood) glucose result was fasted, random or
part of a glucose tolerance test.2 This time we turn our
attention to the use of ‘greater than’ (>) or ‘less than’
(<) signs in pathology results and their implications
for audit.
The issue: tests of kidney function
and proteinuria are not quoted
for the whole range
The principal issue is that the commonest used blood
test of kidney function – estimation of glomerular
ﬁltration rate (eGFR) is usually not quoted for its entire
range; and often the same happens with proteinuria
tests – these are generally measured as an albumin or
protein creatinine ratio (ACR and PCR, respectively).
eGFR is usually only quoted up to 59 ml/min/1.73
m2; with anything higher reported as 60 ml/min/
1.73 m2 though for some labs it is reported up to 90 ml/
min/1.73m2. The rationale for this is that theremay be
much more variation above 60 ml/min/1.73 m2.3,4
The impact of this when conducting an audit or
quality improvement work and searching oﬀ eGFR
data is that they abruptly stop at 59 ml/min/1.73 m2.
Table 1 illustrated how in a sample of around 17 000 lab
calculated eGFR readings the frequency of recordings
Table 1 Frequency of recording of lab
calculated estimated glomerular ﬁltration
rate (eGFR). Note the cut oﬀ at 59 ml/min/
1.73 m2
eGFR Frequency
ml/min
n %
50 700 4.2
51 767 4.6
52 901 5.5
53 948 5.7
54 1057 6.4
55 1198 7.3
56 1312 8.0
57 1603 9.7
58 1785 10.8
59 1937 11.7
60 0 0.0
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increases, then abruptly stops at 59 ml/min/1.73 m2
(data from the QICKD – Quality Improvement in
Chronic Kidney Disease trial).5 This assay may have
limitations but the artiﬁcial cut-oﬀ limits the audit of
patients and means that people with Stage 2 chronic
kidney disease (CKD; eGFR between 60 and 90 ml/
min/1.73 m2) can readily be identiﬁed.
Proteinuria is generally quoted as a ratio of albumin
or total protein to creatinine as this takes account of
how dilute the urine is. In England ACR is recom-
mended as the standard test for proteinuria.6 This test
was initially widely used as a test for microalbuminuria
in people with diabetes, where it can be associatedwith
complications.7 The current diﬃculty is that where
urine is dilute or contains little protein the test is
reported as ‘undetectable’ as no reliable ratio can be
calculated. Sometimes it is reported as <0.2mg/mmol.
Again, this means a lot of data has no associated
numeric values. The scale of this problem is illustrated
again with a data extraction made as part of the
QICKD trial: in a large sample of ACR results 20.5%
(5400/ 26 375) had no usable numeric value; for PCR
9.7% were unusable (1070/11 013). It is likely that
most of these were very low values and can be inter-
preted as negative tests. In the QICKD trial we make
the assumption these are negative. However, when it
comes to audit and direct patient care this assumption
might reasonably be challenged: some of the early
recording of microalbuminuria in diabetes was car-
ried out with machines that only produced results up
to 20 mg/mmol. Thus, a blank ﬁeld may imply >20
mg/mmol. Confusion is compounded by the existence
of two diﬀerent Read codes for the same measure:
there are both microalbumin:creatinine ratio codes as
well as for ACR.
. Urine albumin: creatinine ratio – ACR (46TC. –
Read 2; XE2n3 – Clinical Terms version 3)
. Urine microalbumin: creatinine ratio (46TD. –
Read 2; XE2n4 – Clinical Terms version 3)
Why does this matter?
The perfect seems to be the enemy of the good
(Volataire (Franc¸ois-Marie Arouet). ‘La Be´gueule’
Published 1772) Whilst sympathetic to the notion
that vague results are generally unhelpful, an inability
to plot trends or conduct audits without secondary
interpretation of data is also important. It is important
for individual patient care, where we may wish to
identify trends and changes in data.More critically it is
important for auditing the quality of care. People with
Stage 2 CKD might not be readily identiﬁed in areas
where results are only quoted up to 59ml/min/1.73m2 ;
with National audits combining results from areas
quoting eGFR up to 90 ml/min/1.73m2. Computer
based audits of proteinuria, using ACR are likely to
ﬁnd 20% less data than those based on hand searching
records.
What should be done?
eGFR should be quoted up to 90ml/min/1.73m2 by all
labs, andACR should always be expressed as a numeric
result. The beneﬁts of data that are readily converted
into information, for the individual patient as well as
for population audits, outweigh the loss of precision.
Let’s avoid precision being the enemy of the good.
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